Transgenomic Scoops Up Clinical Data's Genetic Tests, PGx Products at 'Fair Price' of $15.4M

The purchase of Clinical Data's genetic testing assets gives Transgenomic 11 marketed tests for inherited heart diseases under the Familion brand, PGxPredict tests gauging drug response, tests targeting Fc gamma receptor biomarkers, and a Plavix response test under development.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.